Hub: Pharmaceutical Research and Pricing
The pharmaceutical industry’s core defense of American drug prices is that research and development is expensive, risky, and requires the returns that high prices generate. The documented reality is more complicated. The foundational research underlying most major drugs was funded by the National Institutes of Health — meaning American taxpayers — before private manufacturers acquired … Read more